MARKET

GILD

GILD

Gilead Sciences
NASDAQ

Real-time Quotes | Nasdaq Last Sale

64.03
+0.88
+1.39%
Opening 15:27 01/27 EST
OPEN
63.00
PREV CLOSE
63.15
HIGH
64.28
LOW
62.80
VOLUME
7.13M
TURNOVER
--
52 WEEK HIGH
70.50
52 WEEK LOW
60.89
MARKET CAP
81.00B
P/E (TTM)
30.41
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GILD and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 28 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GILD News

  • Gilead Sciences Option Alert: Mar 20 $62.5 Calls Sweep (50) near the Ask: 984 @ $3.051 vs 1043 OI; Earnings 2/4 After Close Ref=$63.61
  • Benzinga.2h ago
  • Gilead Sciences Option Alert: Fri $64.5 Calls Sweep (15) near the Ask: 505 @ $0.461 vs 3302 OI; Earnings 2/4 After Close Ref=$63.69
  • Benzinga.3h ago
  • Will Soliris, Ultomiris Drive Alexion's (ALXN) Q4 Earnings?
  • Zacks.5h ago
  • Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?
  • Zacks.6h ago

More

Industry

Biotechnology & Medical Research
-0.93%
Pharmaceuticals & Medical Research
-0.34%

Hot Stocks

Name
Price
%Change

About GILD

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.
More

Webull offers Gilead Sciences, Inc. (GILD) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.